Chemed (CHE) Change in Accured Expenses (2009 - 2026)

Chemed has reported Change in Accured Expenses for 18 years, with the latest figure at $4.5 million in Q2 2026.

• Change in Accured Expenses for Q2 2026 came in at $4.5 million, up 686.32% year-over-year; the trailing twelve-month figure through Jun 2026 was $20.1 million (up 135.29% YoY), and the FY2025 annual result was $10.4 million, down 54.18% from the prior year.
• Change in Accured Expenses eased to $4.5 million in Q2 2026, from $6.7 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $13.3 million in Q1 2024 and troughed at -$5.1 million in Q3 2022.
• A 5-year average of $3.0 million and a median of $3.1 million in 2022 frame the typical range for Change in Accured Expenses.
• The widest annual swing landed in 2022, when Change in Accured Expenses plunged 249.56%; it then jumped 686.32% in 2026.
• A 5-year view of Change in Accured Expenses shows it stood at $3.2 million in 2022, then sank by 57.07% to $1.4 million in 2023, then jumped by 219.84% to $4.4 million in 2024, then dropped by 7.54% to $4.1 million in 2025, then rose by 10.15% to $4.5 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $4.5 million in Q2 2026, $6.7 million in Q1 2026, and $4.1 million in Q4 2025.